Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab

NCT00477425 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00477425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00477425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Corrected QT Interval From Clinical Studies Conducted With Bevacizumab
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
June 30, 2007
Completion date
June 30, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma